Articles published by Genentech
Genentech Expands Xofluza® Access and Affordability for Upcoming Flu Season With Direct-to-Patient Launch
Today 11:45 EDT
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types
October 13, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025
September 24, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
New Data for Genentech’s Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)
September 05, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
August 25, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech Provides Update on Phase III Verona Study
June 16, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
From Genentech
Via Business Wire
Tickers
RHHBY



From Genentech
Via Business Wire
Tickers
RHHBY
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer’s at AD/PD 2025
April 03, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
April 02, 2025
From Genentech
Via Business Wire
Tickers
RHHBY


From Genentech
Via Business Wire
Tickers
RHHBY


FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
February 12, 2025
From Genentech
Via Business Wire
Tickers
RHHBY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.